History
  • No items yet
midpage
Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd.
715 F.3d 1363
Fed. Cir.
2013
Read the full case

Background

  • Aventis Pharms., Inc. and AMRI appeal a stipulated noninfringement judgment after a Markman ruling construing the '703 patent.
  • The '703 patent covers processes for making piperidine derivatives using a para-CPK intermediate to yield end products such as fexofenadine, with claims 1, 6, and 7 central to the dispute.
  • The district court construed “substantially pure” and “substantially pure regioisomer” to require at least 98% purity with respect to all impurities, applying this uniformly to both the CPK intermediate and the end product.
  • The district court relied on the prosecution history of the related '610 patent and statements from the inventor in an interference to support a 98% standard.
  • The panel majority reverses, holding that “substantially pure” must have different meanings for the CPK intermediate and the piperidine end product, and adopts a construction closer to the appellants’ position.
  • The case is remanded for reconsideration consistent with the revised claim construction.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether substantially pure applies the same meaning to the CPK intermediate and end product. Aventis urges different meaning for the regioisomer (intermediate) versus end product. AMRI contends there should be a uniform 98% purity standard for both contexts. District court erred; adopt Appellants’ differentiated construction.
What is the proper construction of substantially pure regioisomer in claim 1? Substantially pure regioisomer means largely but not wholly the para isomer. Substantially pure regioisomer should align with a uniform high-purity standard. The term is construed as largely but not wholly the para regioisomer of the intermediate.

Key Cases Cited

  • Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (claim construction guided by intrinsic evidence and ordinary meaning)
  • Markman v. Westview Instruments, Inc., 517 U.S. 370 (Supreme Court 1996) (claims construction is a matter of law)
  • Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576 (Fed. Cir. 1996) (presumption that claim terms carry ordinary meaning; context informs scope)
  • Toro Co. v. White Consol. Indus., Inc., 199 F.3d 1295 (Fed. Cir. 1999) (linguistic and contextual analysis for claim terms)
  • Epcon Gas Sys., Inc. v. Bauer Compressors, Inc., 279 F.3d 1022 (Fed. Cir. 2002) (contextual interpretation of terms like substantially)
Read the full case

Case Details

Case Name: Aventis Pharmaceuticals Inc. v. Amino Chemicals Ltd.
Court Name: Court of Appeals for the Federal Circuit
Date Published: May 20, 2013
Citation: 715 F.3d 1363
Docket Number: 2011-1335, 2011-1336
Court Abbreviation: Fed. Cir.